Raven biosciences ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Raven biosciences ApS
Raven biosciences ApS (CVR number: 39085127) is a company from AARHUS. The company reported a net sales of 5.1 mDKK in 2024, demonstrating a decline of -27.8 % compared to the previous year. The operating profit percentage was poor at -24.4 % (EBIT: -1.2 mDKK), while net earnings were -925.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -18.1 %, which can be considered poor and Return on Equity (ROE) was -32.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 34 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Raven biosciences ApS's liquidity measured by quick ratio was 1.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsNet sales (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 2 243.53 | 5 956.86 | 12 670.19 | 7 055.10 | 5 095.38 |
Gross profit | 2 104.79 | 3 398.52 | 7 482.86 | 5 992.86 | 4 114.84 |
EBIT | - 321.51 | 918.03 | 3 482.70 | 732.81 | -1 242.52 |
Net earnings | - 255.47 | 710.15 | 2 477.56 | 429.53 | - 925.20 |
Shareholders equity total | 413.04 | 1 015.09 | 3 492.66 | 3 921.95 | 1 796.75 |
Balance sheet total (assets) | 974.52 | 2 986.79 | 7 938.95 | 7 284.87 | 5 278.14 |
Net debt | - 405.54 | - 709.51 | -2 774.48 | -6 094.27 | -3 490.05 |
Profitability | |||||
EBIT-% | -14.3 % | 15.4 % | 27.5 % | 10.4 % | -24.4 % |
ROA | -30.7 % | 46.4 % | 67.1 % | 10.8 % | -18.1 % |
ROE | -47.2 % | 99.5 % | 109.9 % | 11.6 % | -32.4 % |
ROI | -59.5 % | 128.6 % | 162.7 % | 22.2 % | -39.8 % |
Economic value added (EVA) | - 284.37 | 695.31 | 2 665.00 | 607.13 | -1 166.24 |
Solvency | |||||
Equity ratio | 42.4 % | 34.0 % | 44.0 % | 53.8 % | 34.0 % |
Gearing | |||||
Relative net indebtedness % | 7.0 % | 21.2 % | 13.2 % | -38.7 % | -0.2 % |
Liquidity | |||||
Quick ratio | 1.7 | 1.5 | 1.8 | 2.2 | 1.5 |
Current ratio | 1.7 | 1.5 | 1.8 | 2.2 | 1.5 |
Cash and cash equivalents | 405.54 | 709.51 | 2 774.48 | 6 094.27 | 3 490.05 |
Capital use efficiency | |||||
Trade debtors turnover (days) | 71.8 | 127.3 | 135.1 | 33.0 | 67.4 |
Net working capital % | 18.4 % | 17.0 % | 27.6 % | 55.6 % | 35.3 % |
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BB |
Variable visualization
Roles
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.